.png)
PCOS Is Now PMOS: Why the Name Change Matters for Women’s Health
For decades, millions of women have known the condition as polycystic ovary syndrome, or PCOS. In May 2026, that officially changed. Following an extensive international consensus process, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS.
At first glance, changing the name of a medical condition might not seem particularly significant. But for those who have spent years trying to understand their symptoms, searching for answers, or being told that PCOS is simply an issue with their ovaries, this change represents something much bigger.
The new name reflects what research and many women living with the condition have understood for years: this is about much more than ovarian cysts.
Why Was PCOS Renamed?
The term “polycystic ovary syndrome” dates back to the 1930s and placed significant focus on the appearance of the ovaries. We now understand that the structures commonly seen on ultrasound are not actually ovarian cysts in the traditional sense.
They represent follicles at particular stages of development. More importantly, someone does not need to have polycystic-appearing ovaries to meet the diagnostic criteria for the condition.
That creates an obvious problem. Imagine being told you have “polycystic ovary syndrome” while also being told that you do not actually have ovarian cysts.
Understandably, the terminology has created confusion for patients and healthcare professionals alike.
The name also placed tremendous emphasis on the reproductive system when the condition reaches far beyond reproduction.
PMOS can involve hormonal, metabolic, reproductive, dermatological, and psychological health. Common features can include irregular menstrual cycles, ovulatory dysfunction, elevated androgen levels, acne, excess facial or body hair, difficulty with weight management, insulin resistance, fertility challenges, and other metabolic concerns. The presentation can also look very different from one person to another.
The 2023 International Evidence-Based Guideline already emphasized the importance of considering reproductive, metabolic, cardiovascular, dermatological, sleep, and psychological features when assessing and managing the condition.
Calling it PMOS gives us language that better reflects that complexity.
What Does PMOS Stand For?
PMOS stands for Polyendocrine Metabolic Ovarian Syndrome.
Each part of the name is intentional.
Polyendocrine recognizes that multiple hormonal and endocrine pathways may be involved rather than framing the condition as an isolated ovarian problem.
Metabolic acknowledges an important part of the condition that was largely invisible in the old name. Metabolic health, including insulin resistance and increased risks for impaired glucose tolerance and type 2 diabetes, deserves appropriate attention when caring for someone with PMOS.
Ovarian remains in the name because ovarian and reproductive function are still important components of the syndrome. The difference is that the ovaries are no longer presented as the entire story.
Syndrome remains appropriate because PMOS represents a collection of signs, symptoms, and physiological changes that can present differently between individuals.
This Wasn’t an Overnight Decision
The transition from PCOS to PMOS was not simply a few researchers deciding they preferred a different acronym.
The process took approximately 14 years of international collaboration and included more than 22,000 survey responses, global workshops, and input from more than 50 professional and patient organizations. Importantly, women living with the condition played a major role in the process.
That patient involvement matters.
Medical terminology should help people understand their health, not create unnecessary confusion or reinforce misconceptions. The previous name could make someone believe that ovarian cysts were the defining feature of the condition or that PMOS only mattered when trying to become pregnant.
Neither is true.
Does the New Name Change the Diagnosis?
One important point is that PMOS is not a new disease or a new diagnosis.
If you were previously diagnosed with PCOS, your diagnosis has not suddenly disappeared or changed into a different condition. PMOS is the new terminology for the same syndrome.
The 2026 terminology update specifically states that the recommendations and content of the current International Evidence-Based Guideline remain unchanged.
The next international guideline, expected in 2028, will incorporate PMOS as the standard terminology throughout.
During this transition, you may continue seeing both terms. Healthcare providers, research articles, medical records, and educational materials may use PCOS, PMOS, formerly PCOS, or PMOS/PCOS as terminology gradually changes.
Why This Change Could Improve Care
Perhaps one of the most meaningful parts of the transition to PMOS is the opportunity to change how we think about care.
When we view this condition primarily through the ovaries, treatment can easily become centered around menstrual cycles, birth control, androgen-related symptoms, or fertility. Those concerns absolutely matter, but they are only part of the picture.
A more comprehensive approach asks broader questions.
How is metabolic health? Are there signs of insulin resistance? How is sleep? What is happening with menstrual and reproductive health? Are androgen-related symptoms affecting quality of life? What cardiovascular risk factors are present? How is the individual doing emotionally?
The goal should not be to treat an acronym. It should be to understand the whole person experiencing the condition.
This is especially important because PMOS does not look identical in every woman.
Two people can carry the same diagnosis and experience very different symptoms, priorities, and health concerns. Effective care should reflect that individuality.
A New Name and a Broader Conversation
For those who have lived with PCOS for years, it may take some time before saying “PMOS” feels natural. That is completely understandable. PCOS has been part of women’s health terminology for generations.
But the transition represents meaningful progress.
Polyendocrine metabolic ovarian syndrome acknowledges that this condition is not simply about cysts. It is not simply about periods. And it is not simply about fertility.
It is a complex endocrine and metabolic condition that deserves comprehensive, individualized care.
At Dynamic Wellness Collaborative, we believe women’s health concerns deserve to be viewed through a whole-person lens. As PCOS becomes PMOS, we hope the changing terminology also encourages a broader conversation about hormonal and metabolic health and helps more women feel empowered to ask questions, understand their bodies, and advocate for comprehensive care.
References
American Society for Reproductive Medicine. (2026). PCOS is now PMOS: Understanding the name change.
Monash Centre for Health Research and Implementation. (2026). International evidence-based guideline: Terminology update, polycystic ovary syndrome (PCOS) renamed polyendocrine metabolic ovarian syndrome (PMOS).
Teede, H. J., et al. (2023). Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Human Reproduction, 38(9), 1655–1679.
Comments